Nebido® - The only long-acting injectabletestosterone replacement therapy (TRT)
Hypogonadism (testosterone deficiency)
Male hypogonadism is a clinical syndrome resulting from a failure of the testes to produce physiological levels of testosterone (androgen deficiency), sperm, or both, because of disruption of one or more levels of the hypothalamic-pituitary-gonadal axis.
Testosterone tools
Try out our four helpful Testosterone Tools. They make it much easier to manage the treatment of hypogonadism. These tools allow for easy testosterone conversion and free testosterone calculation, provide an algorithm for diagnosis and treatment of hypogonadism, and a visualization of when each of the many beneficial testosterone effects can be expected to manifest.
Testosterone replacement therapy (TRT)
The essential aim of testosterone replacement therapy is to restore serum testosterone to the middle of the normal physiological range and to minimize the signs and symptoms of hypogonadism.
Treatment guidelines
Guidelines and recommendations issued by medical societies on the definition, investigation, treatment and follow-up of men with late-onset hypogonadism.
Nebido® product information
Long term treatment therapy with Nebido® increases the improvement of erectile dysfunction, sexual mood, metabolic syndrome, muscle mass and strength.
Find answers to treatment, advantages, dosage and side effects of using Nebido®.
Latest news on men's health matters
28 January 2021
Testosterone therapy for prevention and reversal of type 2 diabetes in men enrolled in a lifestyle program
Read more 
01 July 2019
